As at November 5, 2020, we had 62,678,613 common shares issued and outstanding, as well as 326,410 stock options, 173,000 deferred share units and 47,232,366 share purchase warrants outstanding. As at September 30, 2020 we had $21.8 million of cash and cash equivalents.
Nach Q4 sollten es um die 26 Mio$ sein. Warrants as at August 5, 2020
|
| Warrants |
|
| Exercise Price |
|
|
|
|
| # |
|
| $ |
|
| Expiry date | December 2015 registered direct offering |
|
| 2,331,000 |
|
|
| 7.10 |
|
| December 13, 2020 | September 2019 registered direct offering |
|
| 3,325,000 |
|
|
| 1.65 |
|
| September 24, 2024 | February 2020 Financing |
|
| 2,608,696 |
|
|
| 1.20 |
|
| August 21, 2025 | February 2020 Financing |
|
| 243,478 |
|
|
| 1.61719 |
|
| February 19, 2025 | July 2020 Financing |
|
| 26,666,666 |
|
|
| 0.45 |
|
| July 7, 2025 | July 2020 Financing |
|
| 1,866,667 |
|
|
| 0.5625 |
|
| July 1, 2025 | August 2020 Financing |
|
| 9,320,907 |
|
|
| 0.47 |
|
| February 5, 2026 | August 2020 Financing |
|
| 869,952 |
|
|
| 0.7040625 |
|
| August 3, 2025 |
|
|
| 47,232,366 |
|
|
|
|
|
|
|
Termine 2020: Q1 ---- Ende PIP 01 (Kindrstudie) 10. März --- Ende der Serie A Warrants 24. März ----- Die 1,65$ September 2019 Warrants dürfen ausgeübt werden 1 April -------Beneficial Ownership Determination Date/ Record Date for Voting 6.April ------- Finale Ergebnisse PIP 01 (positive Results In Dose-finding) 1. Mai ------- Ende der 945T 4,7$ Warrants 15. Mai ------- Annual Meeting 8 Juni -------- Registrierung der 2019 und 2020 Warrants (Verkauf über den Markt zulässig) 25 Juni -------- Megapharm Distribution Agreement (ISRAEL AND THE PALESTINE) 7 Juli ----------- CLOSING OF $12 MILLION PUBLIC OFFERING 5.August -------- CLOSING OF $7 MILLION PUBLIC OFFERING
16.Nov ------------- Novo Lizenzdeal (Kompl. Rechte Mac US) 7. Dez. ------------- Consilient Health Ltd (Verkaufsrechte Mac AGHD)
13. Dez ---------- Ende der 2,33 Mio 7,1$ Warrants Termine 2021
25. Jan ----------- NASDAQ 1$ Regel (Ende erste 180 Tage) Q1. -------- geplant Anfang PIP 02 März ------------ Möglich: Hauptversammlung April ---------------- Möglich: RS (Kann erst nach Zustimmung der Aktionäre) Ende Juli ----------- NASDAQ 1$ Regel (Ende zweite 180 Tage) mögliches Delisting Q2 2022------- geplant Ende PIP 02 min Q3 2023 ------------- AEterna mögliche EMA/FDA Zulassung pediatric US / EU Q1 2024 --------------- Ende Kohle ohne Pipeline :-)))))
|